Related Experiment Video
Updated: May 9, 2026

06:03
Operational and Intervention Effects of Targeted Tuina in Lumbar Intervertebral Disc Degeneration Model Rabbits
Published on: July 21, 2023
Rational treatment of low back trouble?
Clinical Biomechanics (Bristol, Avon)
|August 7, 2013
Summary
Treating low back pain is often empirical. Future research should focus on clinical trials that consider the natural history of back conditions for better therapeutic validation.
Area of Science:
- Clinical Medicine
- Evidence-Based Practice
- Health Services Research
Background:
- Low back pain treatment lacks robust scientific validation, relying heavily on empirical approaches.
- Controlled clinical trials are essential for validating therapeutic options for low back pain.
- Challenges exist in designing effective clinical trials for low back pain interventions.
Purpose of the Study:
- To discuss the inherent problems in constructing clinical trials for low back pain.
- To advocate for resource allocation towards identifying clinical syndromes with predictable natural histories.
- To recommend that future therapeutic efficacy trials consider the natural history of low back pain.
Main Methods:
- Literature review and critical analysis of existing clinical trial methodologies for low back pain.
- Discussion of the challenges in designing and implementing controlled clinical trials.
- Conceptual framework development for integrating natural history into trial design.
Main Results:
- Empirical treatment remains prevalent for low back pain, highlighting a gap in evidence-based practice.
- Significant methodological challenges impede the construction of rigorous clinical trials.
- Identification of clinical syndromes with predictable natural histories is crucial for trial design.
Conclusions:
- Future research should prioritize the identification of distinct low back pain syndromes with predictable natural histories.
- Controlled clinical trials for low back pain therapies must incorporate the natural history of the condition.
- A shift towards syndrome-specific, natural history-informed trials is recommended for advancing evidence-based treatment.
